CDLX vs. RZLV, CRNC, CCSI, CANG, PERI, BIGC, TBRG, ATGL, MIXT, and KLTR
Should you be buying Cardlytics stock or one of its competitors? The main competitors of Cardlytics include Rezolve AI (RZLV), Cerence (CRNC), Consensus Cloud Solutions (CCSI), Cango (CANG), Perion Network (PERI), BigCommerce (BIGC), TruBridge (TBRG), Alpha Technology Group (ATGL), MiX Telematics (MIXT), and Kaltura (KLTR). These companies are all part of the "computer software" industry.
Cardlytics vs.
Cardlytics (NASDAQ:CDLX) and Rezolve AI (NASDAQ:RZLV) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings.
In the previous week, Cardlytics had 8 more articles in the media than Rezolve AI. MarketBeat recorded 10 mentions for Cardlytics and 2 mentions for Rezolve AI. Rezolve AI's average media sentiment score of 0.79 beat Cardlytics' score of 0.51 indicating that Rezolve AI is being referred to more favorably in the news media.
Cardlytics has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, Rezolve AI has a beta of -0.51, meaning that its stock price is 151% less volatile than the S&P 500.
Rezolve AI has lower revenue, but higher earnings than Cardlytics.
68.1% of Cardlytics shares are held by institutional investors. Comparatively, 28.0% of Rezolve AI shares are held by institutional investors. 4.4% of Cardlytics shares are held by insiders. Comparatively, 68.7% of Rezolve AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Cardlytics received 214 more outperform votes than Rezolve AI when rated by MarketBeat users. However, 100.00% of users gave Rezolve AI an outperform vote while only 56.68% of users gave Cardlytics an outperform vote.
Cardlytics currently has a consensus target price of $5.20, suggesting a potential upside of 144.82%. Rezolve AI has a consensus target price of $6.00, suggesting a potential upside of 169.66%. Given Rezolve AI's stronger consensus rating and higher probable upside, analysts clearly believe Rezolve AI is more favorable than Cardlytics.
Rezolve AI has a net margin of 0.00% compared to Cardlytics' net margin of -93.55%. Rezolve AI's return on equity of 0.00% beat Cardlytics' return on equity.
Summary
Rezolve AI beats Cardlytics on 12 of the 17 factors compared between the two stocks.
Get Cardlytics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardlytics Competitors List
Related Companies and Tools
This page (NASDAQ:CDLX) was last updated on 5/14/2025 by MarketBeat.com Staff
Buy CDLX Stock Free CDLX Stock Alerts